STAT3 contributes to NK cell recognition by modulating expression of NKG2D ligands in adriamycin-resistant K562/AO2
Xiaohui Cai1, Xuzhang Lu2,3, Zhuxia Jia4
1Department of Hematology, The Key Medical Subject of Jiangsu, The Affiliated Hospital of Southeast University, Zhongda Hospital, Hunan Road Dingjia Qiao 87, Nanjing, 210009, China.
Abstract:
Leukemic cells can survive after chemotherapy by acquisition of multidrug resistance genes, but other phenotypes related to escape from immune recognition remain elusive. Adriamycin-resistant K562/AO2 cells are less susceptible to elimination by NK cells compared with wild type K562 cells due to lower expression of NKG2D ligands. Treatment of K562/AO2 cells with STAT3 inhibitor VII resulted in reduced expression of multidrug resistance gene P-glycoprotein, and up-regulation of NKG2D ligands on K562/AO2 cells. Meanwhile, K562/AO2 cells treated with STAT3 inhibitor proliferated less and were more susceptible to killing by NK cells than untreated K562/AO2 cells. The enhanced cytotoxicity of NK cells against K562/AO2 cells was partly blocked by treatment of NK cells with anti-NKG2D antibodies. These data suggest that STAT3 contributes to NK cell recognition by modulating NKG2D ligands in K562/AO2 cells, which may a mechanism by which cells survive and cause relapse of leukemia.
Insights
STAT3 inhibition enhances natural killer (NK) cell recognition of resistant leukemia cells by increasing NKG2D ligands. This strategy may overcome immune evasion and prevent leukemia relapse.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- Leukemic cells develop multidrug resistance, aiding survival post-chemotherapy.
- Immune evasion mechanisms, beyond drug resistance, are crucial for leukemia cell survival and relapse.
- Adriamycin-resistant K562/AO2 cells show reduced susceptibility to NK cell-mediated killing due to lower NKG2D ligand expression.
Purpose of the Study:
- To investigate the role of STAT3 in modulating immune recognition of drug-resistant leukemic cells.
- To explore the effect of STAT3 inhibition on NK cell cytotoxicity against K562/AO2 cells.
- To determine if STAT3 influences NKG2D ligand expression on leukemic cells.
Main Methods:
- Treatment of K562/AO2 cells with a STAT3 inhibitor (STAT3 inhibitor VII).
- Assessment of multidrug resistance gene P-glycoprotein expression.
- Quantification of NKG2D ligand expression on leukemic cells.
- Evaluation of NK cell cytotoxicity against treated and untreated K562/AO2 cells.
- Blocking experiments using anti-NKG2D antibodies.
Main Results:
- STAT3 inhibition reduced P-glycoprotein expression in K562/AO2 cells.
- STAT3 inhibitor treatment led to up-regulation of NKG2D ligands on K562/AO2 cells.
- Inhibition of STAT3 decreased proliferation and increased susceptibility of K562/AO2 cells to NK cell killing.
- Enhanced NK cell cytotoxicity was partially abrogated by anti-NKG2D antibodies.
Conclusions:
- STAT3 plays a role in evading NK cell recognition by modulating NKG2D ligands on leukemic cells.
- Targeting STAT3 can restore NK cell-mediated immunity against drug-resistant leukemia.
- STAT3 inhibition represents a potential therapeutic strategy to overcome immune escape and prevent leukemia relapse.
More Related Videos
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...


